Drawing for NORTHERN LIPIDS

USPTO serial 79212614

NORTHERN LIPIDS

Reviewed by CopyMark Law Group

Reg. 5505390Status 709
Filing date
Status date
Registration date
Jul 3, 2018
Examiner
BLOHM, LINDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NORTHERN LIPIDS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry with exception of manures; chemical auxiliaries and intermediate products for the manufacture of pharmaceutical and cosmetic products; unprocessed artificial resins, unprocessed plastics; unprocessed artificial resins in the form of powders, granules, solutions, emulsions, dispersions, and pastes, in particular for use as auxiliaries for the manufacture of pharmaceutical products; biodegradable polymers for medical and pharmaceutical use; acrylic polymers for medical and pharmaceutical use; polymethylmethacrylate; lactides for industrial purposes, lactides for use in pharmaceuticals, lactides for use in manufacture, lactides for use in the manufacture of pharmaceutical products; glycolides for industrial purposes, glycolides for use in pharmaceuticals, glycolides for use in manufacture, glycolides for use in the manufacture of pharmaceutical products; dioxanones; trimethylene carbonates; caprolactones; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; adhesives used in industrySECTION 71 - CANCELLED—
005Pharmaceutical and veterinary preparations, namely, drug delivery agents in the form of particles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of a coating for pharmaceutical and medical devices to facilitate the delivery of a wide range of pharmaceuticals and for coating medical implants; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medical and veterinary preparations and articles, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for medical implants; Adjuvants for medical purposes; Drug delivery agents in the nature of coatings, lacquers and glazes for pharmaceutical preparations, veterinary preparations and dietetic substances; Drug delivery agents in the form of coatings, lacquers and glazes that facilitate the delivery of pharmaceutical and veterinary preparations; drug delivery agents in the form of coatings, lacquers and glazes that facilitate the delivery of dietetic substances; chemical preparations for medical, pharmaceutical, veterinary and hygienic purposes, namely, chemical preparations for coating medical implants; chemical preparations for medical, pharmaceutical, veterinary and hygienic purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Esters for pharmaceutical purposes; diagnostic preparations for medical purposes; gamboge for medical purposes; chemical-pharmaceutical preparations for treating medical implants; surgical implants grown from living cells; capsules sold empty for medical purposes; hygienic preparations and articles, namely, disinfectants for hygienic purposes; Dietetic food adapted for medical or veterinary use; nutritional supplements; Dietetic food and substances, namely, nutritional supplements and delivery agents in the form of coatings that facilitate the delivery of nutritional supplements; food for babies; Plasters for medical purposes; materials for dressings, namely, drug delivery gauze; material for stopping teeth; dental impression materials; disinfectants; preparations for destroying vermin; fungicides; herbicidesSECTION 71 - CANCELLED—
040Treatment of materials, namely, processing of chemical and pharmaceutical polymers for the manufacture of chemical, pharmaceutical and veterinary preparations; custom manufacture of chemical, pharmaceutical and veterinary products by means of microencapsulating techniques for others; treatment of materials, namely, processing of biodegradable polymers for medical applications, in particular tissue replacement, bone formation and bone fixation as well as for the manufacture of chemical, pharmaceutical and veterinary preparations; treatment of materials, namely, processing of chemical and pharmaceutical preparations for the controlled release of active ingredients in chemical, pharmaceutical and veterinary preparations; treatment of materials, namely, processing of chemical and pharmaceutical preparations used for surgical, medical, dental and veterinary apparatus and instruments as well as diagnostic apparatus for medical use and apparatus for use in medical analysis; treatment of materials, namely, processing of biodegradable polymers for the manufacture of artificial limbs, artificial implants, stents, syringes for medical purposes, catheter, cannula, acupuncture needles, suture needles, artificial limbs, eyes and teeth, medical guidewires, orthopedic articles, suture materials; custom manufacturing services, namely, custom manufacture of liposomes, liposomal nanoparticles, lipid nanoparticle drug delivery systems, biopolymer microparticles, pharmaceutical formulations, and injectable drug formulations in the field of material processingSECTION 71 - CANCELLED—
042Scientific and technological services, namely, scientific research; Scientific and technological services and research and design relating thereto in the fields of chemicals, specialty chemicals, polymer coatings, pharmaceutical preparations and medical products; industrial analysis and research services in the fields of chemicals, specialty chemicals, polymer coatings, pharmaceutical preparations and medical products; design and development of computer hardware and software; technical consultancy in the field of the manufacture of chemical, pharmaceutical and veterinary preparations using chemical and pharmaceutical polymers; technical consultancy in the field of the use of biodegradable polymers for medical applications; quality control and material testing; Providing technical expert opinions in the fields of nanoscience, bioscience, drug delivery systems and biotechnology; materials testing and analysis; chemistry services, namely, chemistry consultation; engineering services; bacteriological or chemical laboratory services; physics researchSECTION 71 - CANCELLED—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals; Agriculture services, namely, agricultural advice; horticulture services; consultancy and information services in the field of pharmaceutical compounding, pharmaceutical development and pharmaceutical drug delivery systemsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 19, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 28, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 28, 2026INPCINVALIDATION PROCESSED—
Sep 17, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 17, 2025C71TCANCELLED SECTION 71—
May 14, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 26, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 10, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 10, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 3, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 13, 2018GPNXNOTIFICATION PROCESSED BY IB—
Mar 28, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 28, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 28, 2018NPUBNOTICE OF PUBLICATION—
Mar 12, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2018CNEAEXAMINERS AMENDMENT MAILED—
Mar 12, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 12, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 6, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 27, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 15, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 12, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 9, 2018ALIEASSIGNED TO LIE—
Feb 1, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2017RFNTREFUSAL PROCESSED BY IB—
Aug 1, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 1, 2017RFRRREFUSAL PROCESSED BY MPU—
Jul 28, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 27, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 21, 2017DOCKASSIGNED TO EXAMINER—
Jul 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance